Consensus
The community sees this as very unlikely for Novo Nordisk at 14%, based on 7 forecasts. Forecasters are in moderate agreement.
Resolves YES if Novo Nordisk is down more than 36% 12 months out versus its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole nvo discussion →